In neuroblastoma, frequent MYCN amplification and chromosome 17q gain are found only in advanced stages of the disease (Brodeur et al., 1984; Bown et al., 1999), so they are unlikely to be the initiating rate-limiting events. This evidence concerns the gene MYCN and neuroblastoma.